Bioasis Technologies Profit Margin

Bioasis Technologies (BTI.V) currently reports a profit margin of -1067.59% as of November 2022. That compares with -9235.89% in the prior-year period — up 88.4% year over year. That is below the Healthcare sector average of 9.48%. Use the charts on this page to explore Bioasis Technologies's profit margin history and peer comparisons.

Bioasis Technologies's profit margin increased from -9235.89% to -1067.59% — a 88.4% year-over-year increase (period ending November 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bioasis Technologies's profit margin of -1067.59% is lower than the Healthcare sector average of 9.48%. That is roughly 11360.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Bioasis Technologies's current -1067.59% should be judged against Healthcare norms (sector average: 9.48%) and against BTI.V's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1067.59%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.48%. From there, open related valuation or income-statement pages for Bioasis Technologies, and consider following BTI.V for alerts when major investors trade the stock.